Table 2.
Cutaneous | Mucosal | |||||||
---|---|---|---|---|---|---|---|---|
Cases | 5-year Survival Estimate | Cases | 5-year Survival Estimate | |||||
N | % | Survival Estimate (%) | 95% CI (%) | N | % | Survival Estimate (%) | 95% CI | |
Stage at Diagnosis | ||||||||
Localized | 109,982 | 84.00% | 82.87 | 82.62, 83.12 | 790 | 43.31% | 43.93 | 40.13, 47.67 |
Regional | 10,515 | 8.03% | 50.58 | 49.52, 51.64 | 518 | 28.40% | 18.76 | 15.20, 22.62 |
Remote | 5,773 | 4.41% | 13.50 | 12.54, 14.50 | 384 | 21.05% | 7.84 | 5.13, 11.29 |
Unknown | 4,657 | 3.56% | 55.65 | 54.09, 57.19 | 132 | 7.24% | 20.97 | 13.98, 28.93 |
Total Cases | 130,927 | 1,824 |